IN'OYA Laboratoire Overview
- Year Founded
-
2011
- Status
-
Private
- Employees
-
19
- Latest Deal Type
-
2ndary - Private
- Investors
-
11
IN'OYA Laboratoire General Information
Description
Developer of cosmetic and skin care products designed for dark and olive skin tones. The company's products focus on the treatment of hyperpigmentation spots that include serums and moisturizers without side effects, which take genes into account, enabling women to tackle all their skin-related issues.
Contact Information
Website
inoya-laboratoire.comCorporate Office
- Pôle d'activités, Y. Morandat 1480
- Avenue d'Arménie
- 13120 Gardanne
- France
Corporate Office
- Pôle d'activités, Y. Morandat 1480
- Avenue d'Arménie
- 13120 Gardanne
- France
IN'OYA Laboratoire Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
4. Secondary Transaction - Private | Completed | Generating Revenue | ||||
3. Later Stage VC | 23-May-2018 | Completed | Generating Revenue | |||
2. Early Stage VC | 07-Jan-2015 | $747K | $747K | Completed | Generating Revenue | |
1. Accelerator/Incubator | Completed | Startup |
IN'OYA Laboratoire Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Ordinary Shares | ||||||||
Ordinary Shares |
IN'OYA Laboratoire Patents
IN'OYA Laboratoire Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
FR-3078891-A1 | Use of ilex aquifolium extract for the treatment of pigmentation disorders and skin laundering | Active | 16-Mar-2018 | ||
FR-3078891-B1 | Use of an ilex aquifolium extract for the treatment of pigmentation disorders and for bleaching of the skin | Active | 16-Mar-2018 | ||
EP-3765161-A1 | Use of an ilex aquifolium extract for treating skin pigmentation disorders and for skin whitening | Active | 16-Mar-2018 | ||
EP-3765161-B1 | Use of an ilex aquifolium extract for the treatment of pigmentation disorders and for skin bleaching | Active | 16-Mar-2018 | ||
CA-2906241-A1 | Use of spider venoms for skin whitening/depigmenting and composition comprising spider venoms molecules or synthetic analogs | Inactive | 05-Sep-2012 | A61K8/987 |
IN'OYA Laboratoire Signals
IN'OYA Laboratoire Investors (11)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Banque Populaire Méditerranée | Lender/Debt Provider | Minority | ||
Bpifrance | Sovereign Wealth Fund | Minority | ||
CAAP Creation | Venture Capital | Minority | ||
European Regional Development Fund (Brandenburg) | Government | Minority | ||
KYOSEIL AM | Asset Manager | Minority |
IN'OYA Laboratoire FAQs
-
When was IN'OYA Laboratoire founded?
IN'OYA Laboratoire was founded in 2011.
-
Where is IN'OYA Laboratoire headquartered?
IN'OYA Laboratoire is headquartered in Gardanne, France.
-
What is the size of IN'OYA Laboratoire?
IN'OYA Laboratoire has 19 total employees.
-
What industry is IN'OYA Laboratoire in?
IN'OYA Laboratoire’s primary industry is Personal Products.
-
Is IN'OYA Laboratoire a private or public company?
IN'OYA Laboratoire is a Private company.
-
What is IN'OYA Laboratoire’s current revenue?
The current revenue for IN'OYA Laboratoire is
. -
How much funding has IN'OYA Laboratoire raised over time?
IN'OYA Laboratoire has raised $1.03M.
-
Who are IN'OYA Laboratoire’s investors?
Banque Populaire Méditerranée, Bpifrance, CAAP Creation, European Regional Development Fund (Brandenburg), and KYOSEIL AM are 5 of 11 investors who have invested in IN'OYA Laboratoire.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »